Niki BioSolutions, Inc. Cash and Cash Equivalents
Niki BioSolutions, Inc. (NIKI) had Cash and Cash Equivalents of $3.45 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-05-11
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.45M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $874.24K.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $340.31K.
- 2022-06-30: Cash and Cash Equivalents, at Carrying Value $4.07M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $3.45M S-4/A · filed 2026-05-11 |
| 2024-12-31 | $874.24K S-4/A · filed 2026-05-11 |
| 2023-06-30 | $340.31K 6-K · filed 2023-12-22 |
| 2022-06-30 | $4.07M 6-K · filed 2023-12-22 |
| 2020-06-30 | $4.02M 6-K · filed 2020-09-02 |
| 2019-12-31 | $5.19M 6-K · filed 2020-09-02 |
| 2018-12-31 | $12.01M 20-F · filed 2020-04-29 |
| 2017-12-31 | $16.25M 20-F · filed 2019-04-15 |